Transcription of Federal Guidelines for Opioid Treatment Programs
{{id}} {{{paragraph}}}
Example: dental hygienist
Federal Guidelines for Opioid Treatment Programs
0 TABLE OF CONTENTS Federal Guidelines FOR Opioid Treatment Programs January 2015 Federal Guidelines FOR Opioid Treatment Programs Acknowledgments This publication was prepared for under contract number HHSS28320070053I/HHSS28342003T by the Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS). Nichole Washington Smith served as the Government Project Officer. Disclaimer The views, opinions, and content expressed herein are the views of the consensus panel members and do not necessarily reflect the official position of SAMHSA or HHS. No official support of or endorsement by SAMHSA or HHS for these opinions or for the instruments or resources described are intended or should be inferred. The Guidelines presented should not be considered substitutes for individualized client care and Treatment decisions.
Drug Administration.” Currently, these drugs are methadone and pharmaceutical products containing buprenorphine, hereafter referred to as buprenorphine. The regulations apply equally to both of these medications, with the only difference being the time and treatment requirement for unsupervised dosing spelled out in 42 CFR § 8.12(i)(3).
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: